News Search

Category: Startups

Carisma Therapeutics Enters into Definitive Merger Agreement with OrthoCellix to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases  

Carisma Therapeutics, co-founded by Saar Gill, MD, PhD, Associate Professor of Medicine at Penn Medicine, is merging with OrthoCellix.

Lilly Acquires Verve Therapeutics to Advance One-time Treatments for People with High Cardiovascular Risk  

Eli Lilly has acquired Verve Therapeutics, a startup co-founded by Kiran Musunuru.

Penn Spinout Dispatch Bio Emerges from Stealth Mode with $216M in Funding   

Dispatch Bio, co-founded by Carl June, MD, the Richard W. Vague Professor in Immunotherapy at Penn Medicine, is developing a universal cancer treatment for solid tumors.

Penn Spinout Interius Therapeutics To Be Acquired by Kite Therapeutics for $350M

Kite Therapeutics, a Gilead Company, has entered into a definitive agreement to acquire Interius Therapeutics .

Capstan Therapeutics Acquired by AbbVie for $2.1B

AbbVie acquired Capstan, including its lead asset CPTX2309.

App that uses AI to boost caregiving for seniors wins PCI pitch competition at Philly Tech Week   

PCI, Pennovation Works and Philadelphia Alliance for Capital & Technologies (PACT) hosted the “Innovate & Inspire: Research Panel & Pitch Competition” in May.

Dr. Jim Wilson’s Gene Therapy Work with Gemma Biotherapeutics Profiled by the Philadelphia Inquirer   

Gemma Biotherapeutics was co-founded in 2024 by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.

Cerespectus and Vasowatch Join HiveBio’s Inaugural Cohort 

HiveBio has selected its inaugural cohort of underrepresented biotech founders.

Cerespectus Accepted into Science Center’s Capital Readiness Program

Cerespectus was co-founded by Bryan Pukenas, MD, Associate Professor of Radiology in Penn Medicine.

Filter

Skip to content